These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Immunology: new approaches to immuno-modulation and immunotherapy]. Kabelitz D Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979 [No Abstract] [Full Text] [Related]
7. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity. Spreafico F; Mantovani A Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217 [No Abstract] [Full Text] [Related]
8. Future prospects of monoclonal antibodies as magic bullets in immunotherapy. Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304 [TBL] [Abstract][Full Text] [Related]
9. Selected Articles from This Issue. Clin Cancer Res; 2020 Jan; 26(2):323. PubMed ID: 31941683 [No Abstract] [Full Text] [Related]
10. [An overview of antibody-based cancer therapy]. Miao QF; Shao RG; Zhen YS Yao Xue Xue Bao; 2012 Oct; 47(10):1261-8. PubMed ID: 23289136 [TBL] [Abstract][Full Text] [Related]
11. How should clinical data be included in experimental studies of cancer immunology? Gjertsen BT; Bruserud Ø Cancer Immunol Immunother; 2004 Aug; 53(8):677-80. PubMed ID: 15069584 [TBL] [Abstract][Full Text] [Related]
12. Current status and future perspectives of dendritic cell-based cancer immunotherapy. H Yi D; Appel S Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402 [TBL] [Abstract][Full Text] [Related]
13. Radiolabelled monoclonal antibodies in oncology. III. Radioimmunotherapy. Britton KE; Mather SJ; Granowska M Nucl Med Commun; 1991 Apr; 12(4):333-47. PubMed ID: 2067740 [TBL] [Abstract][Full Text] [Related]
14. The immunology of cancer: avenues to immunotherapy. Woods AH Ariz Med; 1973 Jul; 30(7):463-83. PubMed ID: 4581414 [No Abstract] [Full Text] [Related]
15. Application of cell engineering technology to the tumour immunotherapeutic drug: a review. Chen ZN; Xing JL; Bian HJ; Mi L; Jiang JL Cell Biol Int; 2001; 25(10):1013-5. PubMed ID: 11589619 [TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies as antineoplastic antibodies]. Hashimoto Y Nihon Rinsho; 1983; 41(4):821-4. PubMed ID: 6887550 [No Abstract] [Full Text] [Related]
17. Cancer immunotherapy: present status, future perspective, and a new paradigm of peptide immunotherapeutics. Miller MJ; Foy KC; Kaumaya PT Discov Med; 2013 Mar; 15(82):166-76. PubMed ID: 23545045 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody therapy for solid tumors. Green MC; Murray JL; Hortobagyi GN Cancer Treat Rev; 2000 Aug; 26(4):269-86. PubMed ID: 10913382 [TBL] [Abstract][Full Text] [Related]
19. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases]. Jäger E; Jäger D; Knuth A Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776 [No Abstract] [Full Text] [Related]
20. [Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring]. Chouaib S; Echchakir H; Angevin E; Guerra N; Kosmatopoulos K; Caignard A; Lim A; Baron V; Ferradini L; Mami-Chouaib F Bull Cancer; 2001 Aug; 88(8):733-40. PubMed ID: 11578941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]